[Memorandum to Presidential Advisory Council on HIV and AIDS Research Committee Members from Bruce G. Weniger]

PACHA Research Committee - 17-Jan-97 Conference Call - p. 3

10:30 - 11:00
11:00 - 11:15
11:15 - 11:30
11:30 - 11:40

by NIH to lead a revitalized effort for AIDS
vaccines at the agency.
COMMITTEE INTERNAL DISCUSSION
DR. RONALD MOSS (8:00 - 8:15 PST)
Medical Director and Senior Director of
Medical/Scientific Affairs of the Immune
Response Corporation, a biotechnology
company founded by the late Jonas Salk which
has developed an inactivated partial-virus
HIV-1 vaccine for therapeutic use. He is
also Assistant Clinical Professor at the
School of Medicine of the University of
California, San Diego.
ANTHONY S. FAUCI, MD
(Rescheduled from 4 Dec. due to airline
delay.)
Director, National Institute of Allergy
and Infectious Disease (NIAID), NIH, and the
concurrent Chief of the Laboratory of
Immunoregulation, NIAID. A world authority
in immunology and diseases affecting the
immune system, including HIV. Member of the
National Academy of Sciences, the Institute
of Medicine, and numerous other prestigious
scientific organizations, editorial boards,
and professional societies, and recipient of
many scientific awards.
More Committee Housekeeping; Announcements

END OF CALL
ATTACHMENTS (faxed): Dr. Ronald Moss, oral statement text
Dr. Raymond Spier, written statement;
editorial (Vaccine 1995;13:1487)